Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arcobacter butzleri: underestimated enteropathogen.

Valérie Prouzet-Mauléon1, Leila Labadi, Nathalie Bouges

  • 1Hõpital Pellegrin, Bordeaux, France.

Emerging Infectious Diseases
|February 24, 2006
PubMed
Summary

Molecular methods identified 29 Arcobacter butzleri infections among 2,855 Campylobacter-like organism strains in France. This finding highlights A. butzleri as a significant pathogen within the Campylobacteraceae family.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg).

Antibiotics (Basel, Switzerland)·2026
Same author

High-resolution 3D chromatin maps reveal PTEN enhancer hubs bridged to the promoter through flanking anchors.

Communications biology·2026
Same author

Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.

Alimentary pharmacology & therapeutics·2026
Same author

Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg): Most relevant results for clinical practice.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Same author

<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group Report.

The New England journal of medicine·2026

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Campylobacter infections are a significant public health concern.
  • Surveillance networks are crucial for tracking bacterial pathogens.
  • The Campylobacteraceae family includes various species with pathogenic potential.

Purpose of the Study:

  • To identify the prevalence of Arcobacter butzleri in Campylobacter-like organism strains.
  • To assess the pathogenic potential of A. butzleri relative to other Campylobacteraceae species.

Main Methods:

  • Molecular methods were employed for strain identification.
  • Analysis of 2,855 Campylobacter-like organism strains from a French surveillance network.

Main Results:

Related Experiment Videos

  • 29 Arcobacter butzleri infections were identified.
  • A. butzleri was the fourth most frequently isolated species in the Campylobacteraceae family.
  • A. butzleri exhibits pathogenic potential comparable to other species within the genus.

Conclusions:

  • Arcobacter butzleri is an emerging pathogen in Campylobacter infections.
  • Molecular surveillance is effective in detecting less common bacterial pathogens.
  • Further research into the pathogenicity of A. butzleri is warranted.